Stay updated on AKB-9778 Tie-2 Activator Clinical Trial
Sign up to get notified when there's something new on the AKB-9778 Tie-2 Activator Clinical Trial page.

Latest updates to the AKB-9778 Tie-2 Activator Clinical Trial page
- Check2 days agoChange DetectedUpdated the page from Revision v3.0.1 to v3.0.2; the old 'Back to Top' navigation was removed. No other substantive content changes were detected.SummaryDifference0.3%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.3%
- Check16 days agoChange DetectedThe web page has been updated to include new facility and drug-related information, while several specific medical terms and location details have been removed.SummaryDifference4%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to include detailed information about the TIME-2 Study, a clinical trial evaluating the safety and efficacy of AKB-9778 for diabetic macular edema, including study details, eligibility criteria, and locations.SummaryDifference100%
Stay in the know with updates to AKB-9778 Tie-2 Activator Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AKB-9778 Tie-2 Activator Clinical Trial page.